In:
Blood Advances, American Society of Hematology, Vol. 2, No. 21 ( 2018-11-13), p. 2811-2813
Kurzfassung:
There is no correlation between ctDNA and bone marrow for MRD by NGS using only immunoglobulin gene rearrangements in myeloma patients.
Materialart:
Online-Ressource
ISSN:
2473-9529
,
2473-9537
DOI:
10.1182/bloodadvances.2018025197
Sprache:
Englisch
Verlag:
American Society of Hematology
Publikationsdatum:
2018
ZDB Id:
2876449-3